title: Concanavalin A, ribose, and adenine resuscitate preserved rat hearts.
abstract: Preserved hearts may have cardiac dysfunction associated with inadequate myocardial high-energy phosphates. To resuscitate preserved hearts, hearts from male Wistar adult rats were preserved in 4.0 degrees C cold-modified Krebs-Henseleit buffer (pH 7.40) for 8 h, subjected to 30 min of reperfusion at 36.5 degrees C with the administration of concanavalin A (Con A; 40 mg/L), ribose (0.1 mM), and adenine (0.1 mM). In comparison with the normal control, the preserved group had a decrease in cardiac output (CO; p < 0.001), myocardial adenosine triphosphate (ATP; p < 0.001), and creatine phosphate (CP; p < 0.001), associated with an increase in myocardial Ca2+ (p < 0.01) and release of myocardial adenine nucleosides (ANs; p < 0.001). In comparison with the preserved group, the group reperfused with ribose and adenine had no improvement of these parameters (p > 0.05). The group reperfused with Con A had an increase in CO (p < 0.01) and myocardial CP (p < 0.01), associated with a decrease in myocardial Ca2+ (p < 0.05) and ANs release (p < 0.01), and no change in myocardial ATP. However, the group reperfused with Con A, ribose, and adenine achieved a significant increase in CO (p < 0.005), ATP (p < 0.005), CP (p < 0.005), and a decrease in myocardial Ca2+ (p < 0.01) and ANs release (p < 0.01). Data suggest that the combination of Con A, ribose, and adenine may resuscitate cold-preserved rat hearts.
authors.affiliation: Department of Surgery, State University of New York at Buffalo, U.S.A.
authors.forename: Z T
authors.initials: ZT
authors.lastname: Tan
authors.forename: J N
authors.initials: JN
authors.lastname: Bhayana
authors.forename: J
authors.initials: J
authors.lastname: Bergsland
authors.forename: X W
authors.initials: XW
authors.lastname: Wang
authors.forename: E L
authors.initials: EL
authors.lastname: Hoover
mesh_terms: D000225:Adenine / Q000494:pharmacology*; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D002118:Calcium / Q000378:metabolism; D003208:Concanavalin A / Q000494:pharmacology*; D003402:Creatine Kinase / Q000378:metabolism; D006321:Heart / Q000187:drug effects* / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D015425:Myocardial Reperfusion; D009206:Myocardium / Q000201:enzymology / Q000378:metabolism; D009705:Nucleosides / Q000378:metabolism; D009926:Organ Preservation / Q000009:adverse effects*; D010710:Phosphates / Q000378:metabolism; D010725:Phosphocreatine / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D012266:Ribose / Q000494:pharmacology*
chemical_list: D009705:Nucleosides; D010710:Phosphates; D010725:Phosphocreatine; D003208:Concanavalin A; D012266:Ribose; D000255:Adenosine Triphosphate; D003402:Creatine Kinase; D000225:Adenine; D002118:Calcium